PL2744831T3 - Białko fuzyjne transferryna-tumstatyna oraz sposoby jego wytwarzania i stosowania - Google Patents
Białko fuzyjne transferryna-tumstatyna oraz sposoby jego wytwarzania i stosowaniaInfo
- Publication number
- PL2744831T3 PL2744831T3 PL12824616T PL12824616T PL2744831T3 PL 2744831 T3 PL2744831 T3 PL 2744831T3 PL 12824616 T PL12824616 T PL 12824616T PL 12824616 T PL12824616 T PL 12824616T PL 2744831 T3 PL2744831 T3 PL 2744831T3
- Authority
- PL
- Poland
- Prior art keywords
- transferrin
- producing
- methods
- same
- fusion protein
- Prior art date
Links
- 108020001507 fusion proteins Proteins 0.000 title 1
- 102000037865 fusion proteins Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161524508P | 2011-08-17 | 2011-08-17 | |
| PCT/US2012/051013 WO2013025846A2 (en) | 2011-08-17 | 2012-08-15 | Transferrin-tumstatin fusion protein and methods for producing and using the same |
| EP12824616.2A EP2744831B1 (en) | 2011-08-17 | 2012-08-15 | Transferrin-tumstatin fusion protein and methods for producing and using the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2744831T3 true PL2744831T3 (pl) | 2018-05-30 |
Family
ID=47715692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12824616T PL2744831T3 (pl) | 2011-08-17 | 2012-08-15 | Białko fuzyjne transferryna-tumstatyna oraz sposoby jego wytwarzania i stosowania |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9290562B2 (https=) |
| EP (1) | EP2744831B1 (https=) |
| JP (1) | JP6073888B2 (https=) |
| CN (2) | CN110105453A (https=) |
| AU (1) | AU2012296588B2 (https=) |
| BR (1) | BR112014008680A2 (https=) |
| CA (1) | CA2849015C (https=) |
| DK (1) | DK2744831T3 (https=) |
| ES (1) | ES2659161T3 (https=) |
| NO (1) | NO2820418T3 (https=) |
| PL (1) | PL2744831T3 (https=) |
| PT (1) | PT2744831T (https=) |
| SI (1) | SI2744831T1 (https=) |
| TR (1) | TR201802686T4 (https=) |
| WO (1) | WO2013025846A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2995626B1 (en) * | 2013-05-06 | 2018-07-11 | China Pharmaceutical University | Bifunctional fusion proteins to inhibit angiogenesis in tumour microenvironment and to activate adaptive immune responses and the genes and uses thereof |
| US20160137717A1 (en) * | 2013-06-20 | 2016-05-19 | Gabriela Burian | Use of a vegf antagonist in treating choroidal neovascularisation |
| US11058750B2 (en) | 2015-12-03 | 2021-07-13 | Mor Research Applications Ltd. | Compositions and methods for treatment of ocular diseases |
| KR101818151B1 (ko) | 2016-03-25 | 2018-01-16 | 한국과학기술원 | 트렌스페린을 포함하는 허혈성망막병증 예방 및 치료용 조성물 |
| CN109053899B (zh) * | 2017-12-22 | 2021-11-16 | 湖南远泰生物技术有限公司 | 一种含人转铁蛋白抗原表位序列的嵌合体抗原受体 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5672683A (en) | 1989-09-07 | 1997-09-30 | Alkermes, Inc. | Transferrin neuropharmaceutical agent fusion protein |
| US20050192242A1 (en) | 1995-10-11 | 2005-09-01 | Neal Zane C. | Therapeutic fusion protein transgenes |
| CA2331332A1 (en) * | 1998-06-17 | 1999-12-23 | Raghuram Kalluri | Anti-angiogenic proteins and methods of use thereof |
| EP1244701A1 (en) | 1999-12-23 | 2002-10-02 | Human Genome Sciences, Inc. | Transferrin polynucleotides, polypeptides, and antibodies |
| AU2002323501C1 (en) | 2001-08-30 | 2010-04-29 | Biorexis Technology, Inc | Modified transferrin fusion proteins |
| US8129504B2 (en) * | 2001-08-30 | 2012-03-06 | Biorexis Technology, Inc. | Oral delivery of modified transferrin fusion proteins |
| AU2002364586A1 (en) | 2001-12-21 | 2003-07-30 | Delta Biotechnology Limited | Albumin fusion proteins |
| WO2003066824A2 (en) * | 2002-02-07 | 2003-08-14 | Aventis Behring Gmbh | Albumin-fused kunitz domain peptides |
| WO2005034877A2 (en) | 2003-10-10 | 2005-04-21 | University Of Southern California | G-csf transferrin fusion proteins |
| US20050266067A1 (en) * | 2004-03-02 | 2005-12-01 | Shiladitya Sengupta | Nanocell drug delivery system |
| US20080207502A1 (en) * | 2004-10-14 | 2008-08-28 | Sopherion Therapeutics, Inc. | Anti-Angiogenic Peptides and Methods of Use Thereof |
| WO2006049983A2 (en) | 2004-10-27 | 2006-05-11 | Biorexis Pharmaceutical Corporation | Peptide yy modified transferrin fusion proteins |
| CA2606989A1 (en) * | 2005-04-29 | 2006-11-09 | Research Development Foundation | Vascular targeting of ocular neovascularization |
| WO2007087689A1 (en) | 2006-02-03 | 2007-08-09 | Crc For Asthma And Airways Ltd | A method of modulating cellular activity and agents for use therein |
| CN101070349B (zh) * | 2007-05-22 | 2010-10-13 | 山西康宝生物制品股份有限公司 | 具有选择性杀伤肿瘤新生血管内皮细胞作用的融合蛋白与应用 |
| CN101092452A (zh) * | 2007-05-23 | 2007-12-26 | 哈尔滨医科大学 | 肿瘤抑素抗血管生成小分子多肽、融合蛋白及两者制备方法 |
| WO2009086132A2 (en) * | 2007-12-20 | 2009-07-09 | University Of Southern California | Design of spacers to increase the expression of recombinant fusion proteins |
| AU2012222833B2 (en) | 2011-03-03 | 2017-03-16 | Zymeworks Inc. | Multivalent heteromultimer scaffold design and constructs |
-
2012
- 2012-08-15 CN CN201910156923.9A patent/CN110105453A/zh active Pending
- 2012-08-15 WO PCT/US2012/051013 patent/WO2013025846A2/en not_active Ceased
- 2012-08-15 CN CN201280051256.4A patent/CN103998470A/zh active Pending
- 2012-08-15 AU AU2012296588A patent/AU2012296588B2/en active Active
- 2012-08-15 TR TR2018/02686T patent/TR201802686T4/tr unknown
- 2012-08-15 ES ES12824616.2T patent/ES2659161T3/es active Active
- 2012-08-15 PT PT128246162T patent/PT2744831T/pt unknown
- 2012-08-15 DK DK12824616.2T patent/DK2744831T3/en active
- 2012-08-15 US US14/239,176 patent/US9290562B2/en active Active
- 2012-08-15 SI SI201231232T patent/SI2744831T1/en unknown
- 2012-08-15 PL PL12824616T patent/PL2744831T3/pl unknown
- 2012-08-15 JP JP2014526189A patent/JP6073888B2/ja active Active
- 2012-08-15 BR BR112014008680A patent/BR112014008680A2/pt unknown
- 2012-08-15 CA CA2849015A patent/CA2849015C/en active Active
- 2012-08-15 EP EP12824616.2A patent/EP2744831B1/en active Active
-
2013
- 2013-07-22 NO NO13745268A patent/NO2820418T3/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK2744831T3 (en) | 2018-03-05 |
| JP6073888B2 (ja) | 2017-02-01 |
| EP2744831A2 (en) | 2014-06-25 |
| NO2820418T3 (https=) | 2018-05-05 |
| EP2744831A4 (en) | 2015-03-11 |
| AU2012296588A1 (en) | 2014-04-03 |
| JP2014526890A (ja) | 2014-10-09 |
| CN110105453A (zh) | 2019-08-09 |
| US9290562B2 (en) | 2016-03-22 |
| BR112014008680A2 (pt) | 2017-06-13 |
| CN103998470A (zh) | 2014-08-20 |
| US20140179612A1 (en) | 2014-06-26 |
| SI2744831T1 (en) | 2018-04-30 |
| CA2849015C (en) | 2017-08-08 |
| WO2013025846A2 (en) | 2013-02-21 |
| CA2849015A1 (en) | 2013-02-21 |
| EP2744831B1 (en) | 2017-12-06 |
| TR201802686T4 (tr) | 2018-03-21 |
| PT2744831T (pt) | 2018-03-05 |
| WO2013025846A3 (en) | 2013-05-02 |
| AU2012296588B2 (en) | 2017-07-27 |
| ES2659161T3 (es) | 2018-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2697187T (pt) | Olefinas e métodos para produção das mesmas | |
| IL240898A0 (en) | Antibodies against a5c and methods of using the antibodies | |
| IL233757A0 (en) | Anti '1m e-gi antibodies and methods of using them | |
| EP2699719A4 (en) | TUBULAR STRUCTURE AND MANUFACTURING METHOD THEREFOR | |
| GB201115529D0 (en) | Antibodies, uses and methods | |
| GB201115280D0 (en) | Antibodies, uses and methods | |
| ZA201400562B (en) | Axmi205 variant proteins and methods for their use | |
| PL2731884T3 (pl) | Pojemnik i sposób jego wytwarzania | |
| LT3321287T (lt) | Sulieti baltymai ir sudėtinės vakcinos | |
| IL232743A0 (en) | anticancer fusion protein | |
| SG10201604332XA (en) | Membrane and method for making the same | |
| SG10201500208SA (en) | Npp1 fusion proteins | |
| PT2661496T (pt) | Proteína de fusão anticancerígena | |
| EP2698386B8 (en) | Fusion protein | |
| ZA201405460B (en) | Anticancer fusion protein | |
| EP2657337A4 (en) | FUSION PROTEIN | |
| ZA201308597B (en) | Anticancer fusion protein | |
| EP2718432A4 (en) | NUCLEASE FUSION PROTEIN AND USES THEREOF | |
| PL2744831T3 (pl) | Białko fuzyjne transferryna-tumstatyna oraz sposoby jego wytwarzania i stosowania | |
| ZA201207425B (en) | Fusion protein | |
| SG2014008601A (en) | Method for producing clean packageing material and the clean packageing material | |
| GB201107189D0 (en) | Fusion proteins | |
| GB201114701D0 (en) | Fusion proteins | |
| AU2011905145A0 (en) | Fusion Protein | |
| AU2011902431A0 (en) | Fusion Proteins and Use Thereof |